- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Daily Derm Times: April 29, 2025
Author(s):
Key Takeaways
- JAK inhibitors show promise for alopecia areata in Black patients, underscoring the need for inclusive research and equitable treatment access.
- FDA approval of pz-cel represents a major advancement in gene therapy for recessive dystrophic epidermolysis bullosa, transforming patient treatment options.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA
JAK inhibitors show promise in treating alopecia areata among Black patients, highlighting the need for inclusive clinical research and equitable access to therapies.
FDA Approves First Gene Therapy for RDEB
The FDA approved pz-cel, a groundbreaking gene therapy for recessive dystrophic epidermolysis bullosa, transforming treatment options for patients.
Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions
The innovative 21-item Hair & Scalp CARE questionnaire is designed to evaluate the psychological impact of hair and scalp conditions on quality of life.
Interview Intersection: Expert Interviews From April 2025
Dermatology Times is recapping our exclusive expert interviews from the month of April.
How Does Psoriasis Influence Sun Tanning Addiction?
Younger patients with moderate to severe psoriasis exhibit risky sun exposure behaviors, raising concerns about tanning addiction and skin cancer risks.
Understanding the Role of OX40 in Next-Generation Eczema Therapies
Acting upstream of cytokines may hold the key to improving biologic efficacy and itch relief in AD.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
